Health Condition 1: I259- Chronic ischemic heart disease, unspecified
Conditions
Interventions
Intervention1: Individualized homoeopathic medicine with standard of care.: Homoeopathic medicines, which are known pharmacopoeial preparations shall be provided to the patients based on the physical
Sponsors
Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt of India
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with complaints of chest discomfort at least once in the last 12 months. 2.Patients wth a 10-year WHO CVD risk prediction score (South Asia-Bangladesh, Bhutan, India, Nepal, Pakistan) of 10% and above in either laboratory or non-laboratory-based charts. All such patients shall be screened for SIHD by ECG. 3.Patient demonstrating ST segment depression by 1mm or more on Stress ECG (Exercise tolerance test). 4.Patients suffering from chest discomfort classified under CCS Functional Score Class I and II. 5.If the patients have medicines for the condition as per the guideline-directed medical therapy shall be accepted (Statin, antihypertensives, aspirin, clopidogrel, and nitroglycerine). 6.Patients with controlled Diabetes Mellitus, hypertension, and Hypothyroidism (if such co-morbidities are present). 7.Patient willing to provide voluntary informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of prior Myocardial Infarction or Coronary Vessel Revascularization. 2. Patients suffering from know conditions of valvular heart diseases (except mild TR, MR), Structural defects of the heart like VSD, ASD, TOF, PDA, Pericarditis, Pericardial effusion, Rheumatic Heart Disease, Cardiac tamponade, Congenital heart disorders, and Conductive disorders of the heart. 3. Patients having prior heart surgeries. 4. Patients suffering from immunocompromised states like Tuberculosis, HIV-AIDS, cancer, under steroid therapy, chemotherapeutic agents, or radiotherapy. 5. Patients having implant of pacemaker device. 6. Pregnant and lactating mothers. 7. Patients suffering from severe mental disorders. 8. Not willing to provide informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Electrocardiogram, ST segment changes as observed by stress/normal ECG conducted by a treadmill test.Timepoint: At baseline, 6 months, 12 months (end of study) | — |
Secondary
| Measure | Time frame |
|---|---|
| Intensity of Angina pectoris using Seattle Angina QuestionnaireTimepoint: Every month from baseline till 12 months;Blood Lipid profileTimepoint: baseline, 6 months & 12 months;Dosage of nitroglycerin required per monthTimepoint: Every month from baseline till 12 months;Occurrence of ADR/SAETimepoint: Every month till 12 months or earlier as per occurrence | — |
Countries
India
Contacts
Public ContactGurudev Choubey
Regional Research Institute for Homoeopathy, Siliguri
Outcome results
None listed